FDAFDA · Food and drugs·Recall number D-0020-2022
GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only, Manufactured by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054. Carton NDC#: 68084-295-21 (Individual Dose NDC: 68084-295-11)
Published October 27, 2021 · Recall initiated: September 17, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: results were above specification.
What to do
Voluntary: Firm initiated
Recall details
- Manufacturer
- American Health Packaging
- Distributor
- Nationwide within the USA
- Lot
- Lot #: 194141, Exp. Date 03/31/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.